Creating Auditable Trails for Returned Drug Destruction in Clinical Trials
Creating Auditable Trails for Returned Drug Destruction in Clinical Trials How to Establish Auditable Trails for Returned Drug Destruction in Clinical Trials Returned Investigational Products (IPs) must undergo a traceable, compliant destruction process to maintain data integrity and fulfill regulatory requirements. Creating auditable trails ensures that every kit, vial, or unit returned from clinical sites…
Read More “Creating Auditable Trails for Returned Drug Destruction in Clinical Trials” »